Healthcare expenditure of intravitreal anti‐vascular endothelial growth factor inhibitors compared with dexamethasone implant for diabetic macular oedema

Acta ophthalmologica (Oxford, England), 2022-12, Vol.100 (8), p.e1630-e1640 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation. ;2022 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation. ;2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1755-375X ;EISSN: 1755-3768 ;DOI: 10.1111/aos.15151 ;PMID: 35467793

Digital Resources/Online E-Resources